BrainStorm Cell Therapeutics
BCLI
#10401
Rank
ยฃ4.97 M
Marketcap
ยฃ0.45
Share price
0.00%
Change (1 day)
-63.60%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total assets

Total assets on the balance sheet as of June 2025 : ยฃ1.92 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total assets are ยฃ1.92 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BrainStorm Cell Therapeutics - Total assets on balance sheet (from 2002 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ1.45 M-55.8%
2023-12-31ยฃ3.3 M-52.72%
2022-12-31ยฃ6.98 M-67.79%
2021-12-31ยฃ21.68 M-42.32%
2020-12-31ยฃ37.6 M654.7%
2019-12-31ยฃ4.98 M-43.67%
2018-12-31ยฃ8.84 M4.65%
2017-12-31ยฃ8.45 M-3.13%
2016-12-31ยฃ8.72 M-24.3%
2015-12-31ยฃ11.52 M81.05%
2014-12-31ยฃ6.36 M122.19%
2013-12-31ยฃ2.86 M-9.87%
2012-12-31ยฃ3.17 M80.06%
2011-12-31ยฃ1.76 M150.26%
2010-12-31ยฃ0.7 M50.8%
2009-12-31ยฃ0.46 M-21.64%
2008-12-31ยฃ0.59 M9.52%
2007-12-31ยฃ0.54 M47.69%
2006-12-31ยฃ0.36 M
2006-03-31ยฃ0.49 M6.58%
2005-03-31ยฃ0.46 M5239.02%
2004-03-31ยฃ0 M-69.7%
2003-03-31ยฃ0.02 M-35.4%
2002-03-31ยฃ0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
ยฃ44.01 B 2,280,998.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ1.08 B 55,884.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
ยฃ2.73 B 141,531.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ21.96 B 1,138,150.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ0.17 B 9,015.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA